APLN and liver dysplastic nodule: To prove that inhibiting proteasome activities is one of the key pathways induced by apelin, which will lead to podocyte injures in DN, we used oleuropein to activate proteasome activities 35,36 to find whether the podocyte injures induced by apelin were reversed or not.